CORDARONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cordarone, and when can generic versions of Cordarone launch?
Cordarone is a drug marketed by Wyeth Pharms Inc and Wyeth Pharms and is included in two NDAs.
The generic ingredient in CORDARONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cordarone
A generic version of CORDARONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORDARONE?
- What are the global sales for CORDARONE?
- What is Average Wholesale Price for CORDARONE?
Summary for CORDARONE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 27 |
Patent Applications: | 4,354 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CORDARONE at DailyMed |
![CORDARONE drug patent expirations Drug patent expirations by year for CORDARONE](/p/graph/s/t/CORDARONE-patent-expirations.png)
Recent Clinical Trials for CORDARONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
OHSU Knight Cancer Institute | Phase 2 |
University of Calgary | Phase 4 |
University Hospital, Caen | Phase 4 |
US Patents and Regulatory Information for CORDARONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | CORDARONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 020377-001 | Aug 3, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Wyeth Pharms | CORDARONE | amiodarone hydrochloride | TABLET;ORAL | 018972-001 | Dec 24, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |